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Abstract
Background: In eukaryotic cells, DNA polymerase d (Pold), whose catalytic subunit p125 is encoded in the Pold1 gene, plays
a central role in chromosomal DNA replication, repair, and recombination. However, the physiological role of the Pold in
mammalian development has not been thoroughly investigated.
Methodology/Principal Findings: To examine this role, we used a gene targeting strategy to generate two kinds of Pold1
mutant mice: Pold-null (Pold1
2/2) mice and D400A exchanged Pold (Pold1
exo/exo) mice. The D400A exchange caused
deficient 39–59 exonuclease activity in the Pold protein. In Pold-null mice, heterozygous mice developed normally despite a
reduction in Pold1 protein quantity. In contrast, homozygous Pold1
2/2 mice suffered from peri-implantation lethality.
Although Pold1
2/2 blastocysts appeared normal, their in vitro culture showed defects in outgrowth proliferation and DNA
synthesis and frequent spontaneous apoptosis, indicating Pold participates in DNA replication during mouse
embryogenesis. In Pold1
exo/exo mice, although heterozygous Pold1
exo/+ mice were normal and healthy, Pold1
exo/exo and
Pold1
exo/2 mice suffered from tumorigenesis.
Conclusions: These results clearly demonstrate that DNA polymerase d is essential for mammalian early embryogenesis and
that the 39–59 exonuclease activity of DNA polymerase d is dispensable for normal development but necessary to suppress
tumorigenesis.
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Introduction
DNA replication is the process for transmitting genetic informa-
tion to future cells and offspring. To date, at least 14 eukaryotic
DNA-dependent DNA polymerases have been found [1–4]. DNA
polymerase a (Pola), DNA polymerase d (Pold) and DNA
polymerase e (Pole) are thought to be distinct DNA polymerases
that directly participate in DNA replication [3,5]. These three
polymerases belong to the type B DNA polymerase subfamily [6].
Pola forms a Pola/RNA primase complex that synthesizes short
RNA-DNAprimersforDNAsynthesis.Ontheotherhand,Poldand
Pole are believed to extend these short primers; Pold is mainly
responsible for lagging strand synthesis while Pole is thought to be
responsible for leading strand synthesis (reviewed in [3,7]). However,
the precise molecular roles of Pold and Pole remain unclear.
Furthermore, in addition to DNA replication, it is known that these
elongating polymerases are also involved in several DNA repair and
recombination pathways [1,5].
Our interest is in Pold, which is a highly processive polymerase
that associates with PCNA. The Pold holoenzyme consists of
several subunits: the catalytic subunit p125 (Pold1), which is
encoded in the Pold1 gene and is highly conserved among
eukaryotes; and two to four more divergent smaller subunits which
are believed to regulate PCNA binding, Pold function and its
structure. Pold1 comprises of two primary functional domains: an
exonuclease domain near the N-terminus that catalyzes 39–59
exonucleolytic proofreading and the subsequent polymerase
domain that catalyzes DNA synthesis.
The molecular functions of Pold had been revealed mainly by
using biochemical analysis and yeast genetics. Studies using the
complete replication of DNA plasmids containing the Simian
Virus 40 (SV40) DNA replication origin with purified mammalian
cell extracts showed that Pold is required for in vitro DNA
replication [8], while a study using Xenopus egg extracts
immunodepleted of Pold also showed the indispensability of Pold
for DNA replication [9]. In fission yeast, temperature-sensitive
mutants and tetrad analysis from diploid heterozygous Pold1-
disrupted mutants showed that Pold1 was essential for viability
while disruption of Pold1 resulted in a terminal phenotype similar
to a cell division cycle mutant, indicating that Pold was involved in
DNA replication [4]. The function of each Pold1 domain has been
investigated extensively by using various yeast mutants. For
example, mutations disrupting 39–59 exonuclease activity caused
a strong mutator phenotype in budding yeast [10,11]. Mutations
in motif A of the polymerase domain also expressed a mutator
phenotype and hypersensitivity to hydroxyurea and methyl-
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4184methane sulfonate in budding yeast [12,13]. Zinc finger domain
deletion mutants showed that the zinc finger domain of Pold1 is
responsible for binding to the regulatory subunit [14]. However,
despite many studies revealing the molecular roles of Pold, the
necessity of Pold in mammalian cell has not been uncovered by a
genetic approach.
Compared to the molecular functions of Pold in eukaryotic cells,
the physiological role of entire Pold in higher eukaryotes remains
obscure. For example, Zebrafish Pold1 disrupted mutants were
found as a result of positional cloning of the flathead gene [15].
Flathead mutants display specific defects in late proliferative zones,
such as eyes, brain and cartilaginous elements of the visceral head
skeleton, where cells showed compromised DNA replication.
However, the zebrafish mutants did develop normally during their
early stages. This may be the result of a functionally redundant
gene of the Pold1 gene due to genomic duplication during teleost
evolution. Using mouse genetics, mice deficient in Pold 39–59
exonucelase activity showed that 39–59 exonuclease activity
suppresses the risk of tumorigenesis as a result of decreasing the
spontaneous mutation rate [16,17]. Mice harboring a mutation in
motif A of the polymerase domain were embryonic lethal in
homozygotes and experienced genomic instability in heterozygotes
as compared to wild types. One motif A mutation, L604K,
reduced the life span and accelerated tumorigenesis in heterozy-
gous mice [18]. However, when, how and why these motif A
mutant homozygotes suffered from death during embryonic
development has not been elucidated well.
In our study, to uncover the physiological role of Pold in
mammalian development more clearly, we generated mice lacking
functional Pold by gene targeting methods in a Pold1
2 allele and
examining its effects. For a more comprehensive analysis, we
generated mice lacking 39–59 exonuclease activity in the Pold of a
Pold1
exo allele. Here, we report that peri-implantation lethality
accompanies the loss of functional Pold. We speculate this is due to
an impairment in cell proliferation, a defect in DNA synthesis and
an occurrence of apoptosis observed in an in vitro blastocyst
outgrowth. Pold is the first DNA polymerase to be studied in such
a model offering new insight on how DNA polymerases are
involved in nuclear chromosomal replication.
Results
Generation of Pold1 gene targeted mice
To analyze the physiological function of the entire Pold and its
39–59 exonuclease activity, we created two types of Pold1 mutant
mice. The Pold1 gene encodes the catalytic subunit p125 of the
Pold complex. This subunit contains the DNA polymerase domain
and 39–59 exonuclease domain. To disrupt the functional murine
Pold1 protein, we inserted a splice/polyadenylation (poly(A)) signal
derived from SV40 into the upstream region encoding the Pold
polymerase domain (schematic in Fig. 1A). Using a point mutation
of GCC from GAC (wild-type), 39–59 exonuclease activity
deficient mice were created by D400A exchange, which is located
in the exonuclease active site (ExoII) and with which mice suffered
from higher tumor susceptibility [16,17]. D400A mutation in mice
has been confirmed to cause inhibition of 39–59 exonuclease
activity by in vitro biochemical analysis [17]. We used the Cre-
mediated loxP recombination system in our gene targeting
strategy to generate the two kinds of Pold1 mutant mice: Pold-
null (Pold1
2/2) mice and its 39–59 exonuclease activity deficient
(Pold1
exo/exo) mice (Fig. 1B) [19].
The Pold1 gene targeting vector was electroporated into
C57BL/6J embryonic stem (ES) cells. G418-resistant clones were
screened for homologous recombination by PCR (Fig. 1C) and
Southern blotting. A point mutation (D400A) was verified by DNA
sequencing. The targeted ES cell clones were microinjected into
Balb/c blastocysts to generate chimeric mice which transmitted
the targeted allele through the germ line. Chimeras were crossed
with C57BL/6J females, yielding Pold1
+/2 mice. The Pold 39–59
exonuclease activity deficient mice were generated by crossing
Pold1
+/2 mice and Cre expressed transgenic animals which
contained a murine Sycp1 gene promoter-Cre transgene that
expressed Cre-recombinase in germ-line cells. Both Pold1
+/2 and
Pold1
exo/+ mice were identified by PCR and Southern blot analysis
(Fig. 1D and 1E).
To confirm the expression of the Pold1 gene from these targeted
alleles, we analyzed mRNA from targeted ES cells. The Pold1
exo/+
ES cells were obtained by electroporating circular Cre-pac plasmids
into Pold1
+/2 ES cells and selecting adequate clones [20]. RT-
PCR was performed on transcripts from Pold1
+/2 and Pold1
exo/+
ES cells using two primers that covered the full-length Pold1 coding
region. Direct sequencing of these RT-PCR products showed that
substituted alleles (GACRGCC) were expressed in Pold1
exo/+ ES
cells, but not in Pold1
+/2 ES cells (Fig. 1F). These results revealed
that full-length mRNA was not expressed from the Pold1
2 allele.
To investigate the expression from mutated alleles in detail, we
determined transcriptional end sites from Pold1
2 alleles by 39
RACE analysis. In 39RACE products from Pold1
+/2 ES cells, both
full-length Pold1 coding fragments and truncated fragments were
observed; while in the products from Pold1
exo/+ ES cells, only the
full-length fragment was observed. After subcloning these
fragments, DNA sequencing was performed. DNA sequencing
showed that truncated fragments from Pold1
+/2 ES cells contained
a substituted sequence (GCC), the 39 terminus was prematurely
stopped by the inserted SV40 poly(A) signal sequence, and these
truncated fragments consisted of two aberrant splicing forms
(Fig. 1G). The full-length fragment sequences from Pold1
+/2 ES
cells only contained the wild-type sequence (GAC) and used an
endogenous poly(A) signal sequence from the Pold1 gene. In
Pold1
exo/+ ES cells, mRNA terminated normally and included both
substituted and wild-type sequences (two and three of five
subclones, respectively). These results suggest that mRNA
terminated by the inserted SV40 poly(A) signal was expressed by
the Pold1
2 allele and the full-length transcript with the D400A
(GACRGCC) substitution was expressed by the Pold1
exo allele. To
confirm that Pold1
2 allele was impaired in the expression of the
Pold1 protein, we analyzed the Pold1 protein by Western blotting.
Western blotting of the extracts prepared from Pold1
+/+ and
Pold1
+/2 E12.5 whole embryos with an anti-Pold1 C-terminal
region antibody showed that the Pold1 protein quantity was
reduced to about half in Pold1
+/2 embryos, while the Pold1
protein quantity from Pold1
+/+ and Pold1
exo/exo E12.5 embryonic
extracts were comparable (Fig. 1H). These results suggest that the
Pold1
2 allele did not function properly due to the prematurely
terminated polymerase domain and that the Pold1
exo allele
expressed quantities of Pold similar to the wild-type allele despite
lacking 39–59 exonuclease activity.
Deficiency of Pold1 causes embryonic lethal around peri-
implantation
Heterozygous Pold1
+/2 mice were apparently normal and fertile
with no detectable developmental abnormalities over 18 months.
No defect in the proliferation of embryonic fibroblasts from these
animals was found (data not shown). In contrast, no homozygous
Pold1
2/2 mice were detected among the 256 live births from
Pold1
+/2 intercrosses (Table 1), indicating that one functional
Pold1 allele is sufficient for embryonic and postnatal development,
whereas inactivation of both alleles leads to embryonic lethality.
Pold in Mouse Embryogenesis
PLoS ONE | www.plosone.org 2 January 2009 | Volume 4 | Issue 1 | e4184Figure 1. Generation of two kinds of Pold1 mutated mice by gene targeting strategy. (A) Schematic of the Pold1 domain structure and
locations of the modifications with a Pold1 gene targeting method. (B) Structure of the targeting vector and partial restriction map of the murine
Pold1 locus before and after homologous recombination and Cre mediated recombination. Exons are represented by vertical black boxes and introns
by intervening horizontal lines. * indicate D400A substitution. The genomic fragment used as a probe for Southern blotting is indicated by the
horizontal blue bar. Restriction enzymes: D indicates DraI; N indicates NheI. PCR primers P0 and P2 were used to screen for homologous recombinant
ES cells. PCR primers P1, P2 and P3 were used for genotyping. (C) PCR screening for homologous recombinants. A 2430-bp band was amplified with
the primer pairs P0–P2, specific to the homologous recombinant. Lane 1–3 are independent homologous recombinant ES clones; lane 4 is a wild-type
ES clone. (D) PCR genotyping of mice tail DNA. A 499-bp wild-type band and a 654-bp Pold1
exo band were amplified with primer pairs P1–P3 and a
334-bp Pold1
2 band was amplified with primer pairs P1–P2. These primers are shown in (B). (E) Southern blot analysis to identify each Pold1 allele
with mouse tail DNA. In DraI digestion, the 15.9-kb fragment corresponds to the wild-type allele, the 16.0-kb fragment corresponds to the Pold1
exo
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Pold1
2/2 embryos, embryos were collected from intercrosses of
Pold1
+/2 mice at different times of gestation and individual
embryos were genotyped by PCR. No homozygous Pold1-deficient
embryos were found at E7.5 or beyond (Table 1). We also
collected embryos at day E3.5 and E4.5 by flushing the uteri of
pregnant females. The homozygous Pold1
2/2 mutant blastocysts
were morphologically indistinguishable from wild-type and
heterozygous embryos (Fig. 2A). These observations indicate that
Pold1
2/2 embryos died between E4.5 and E7.5.
Pold1 is required for the proliferation of blastocyst
outgrowth
To further characterize the developmental abnormality of
Pold1-deficient embryos, we collected E3.5 blastocysts derived
from Pold1
+/2 intercrosses, cultured them in vitro individually for
several days, took photographs, and subsequently genotyped them
by PCR. In Pold1
+/+ and Pold1
+/2 blastocysts, trophoblasts spread
over the culture dish after hatching from the zona pellucida while
an inner cell mass (ICM) grew on the trophoblast sheet after 3 days
of culture. In Pold1
2/2 embryos, the trophoblasts again attached
and spread over the dish, but the trophoblast sheet spread slowly
and the ICM failed to proliferate and degenerated soon after
appearing (Fig. 2B). Pold1-null blastocysts cultured in vitro for a
day, which roughly corresponded to E4.5 in vivo, had no apparent
difference from wild-type and heterozygous embryos. Pold1
2/2
blastocysts cultured for 3 days, roughly corresponding to E6.5,
uncovered a serious proliferation defect.
Lack of Pold1 causes DNA synthesis defects
To uncover whether the proliferation defect of the cultured
Pold1
2/2 blastocysts is due to DNA synthesis inhibition caused by
Pold disruption, we assessed DNA synthesis in cultured blastocysts
by the bromodeoxyuridine (BrdU) incorporation assay. We
cultured blastocysts for 1 or 3 days in normal ES medium and
then cultured them in the presence of BrdU for 3 hr. These
cultured blastocysts were immunostained with a specific antibody
for BrdU. In addition, to assess whether embryonic cells in the
cultured Pold1
2/2 blastocysts entered the mitotic phase, we
simultaneously immunostained them with an antibody against
phosphohistone H3 (Ser-10), a common mitotic marker used to
mark M-phase cells [21]. Incorporation of BrdU into 1 day
cultured blastocyst nuclei revealed no differences between each
genotype, as all embryos showed extensive labeling (Fig. 3A). We
also found phosphohistone H3-positive cells in all embryos
regardless of genotype (Fig. 3A). These results suggested that
Pold1
2/2 embryos were able to synthesize new DNA strands,
equivalent to the S-phase of the cell cycle, and entered the mitotic
phase 1 day after the cultured blastocyst stage. In contrast, in 3
days of cultured blastocyst outgrowth, both the Pold1
+/+ and
Pold1
+/2 outgrowths showed strong incorporation of BrdU and
frequent mitotic stainings into the ICM and trophoblast giant (TG)
cells, but Pold1
2/2 outgrowths showed very little BrdU incorpo-
ration and few mitotic cells(Fig. 3B). In TG cells, it has been shown
that DNA synthesis occurs by endoreduplication, whereby
successive rounds of G and S phases proceed without mitosis
[22,23]. As a result, endocycling giant cells acquire massive
quantities of DNA in their nuclei, thereby becoming polyploid
[24]. This deficiency in Pold1
2/2 outgrowths indicates that the
disruption of Pold caused the distinct DNA synthesis defect
including the TG cell endoreduplication defect.
Deficiency of Pold1 protein results in spontaneous
apoptosis
In the 3rd day of cultured Pold1
2/2 outgrowths stained with
DAPI, we found condensed and fragmented micronuclei, possibly
indicating apoptotic cell death (Fig. 3B). These micronuclei were
rarely found in heterozygous or wild-type outgrowths. To confirm
this apoptotic possibility, TUNEL assays were performed on
blastocyst outgrowths cultured for 3 days. These aberrant nuclei in
Pold1
2/2 outgrowths were all TUNEL-positive, whereas TUNEL-
positive cells were rare in Pold1
+/+ and Pold1
+/2 outgrowths
(Fig. 4). We further explored apoptotic cell death in harvested E3.5
blastocysts. No apparent difference was observed between the
Pold1
2/2 blastocysts (n=4) and the blastocysts with other
genotypes (n=17) (date not shown). These data indicate that
proliferation defects in Pold1
2/2 outgrowths were, at least in part,
due to an occurrence of apoptosis around hatching.
One 39–59 exonuclease deficient Pold1
exo allele enables
embryonic development, but increases tumor
susceptibility
In Pold 39–59 exonuclease activity deficient mice, it has been
shown that the mutant allele does not affect embryo viability and
that homozygous mutant mice are fertile. However, recessive
mutants are more prone to cancer and death [16,17]. To confirm
the physiological role of Pold 39–59 exonuclease activity and to
examine an interaction between the Pold1
exo allele and the Pold1
2
allele, we analyzed this exonuclease activity disrupted mice. We
found similar observations as those in [16,17] for Pold1
exo/exo and
Pold1
exo/+ mice, as both were able to grow normally and were
fertile (Table 2). At embryonic stage E12.5, no morphological
differences between Pold1
exo/exo and wild-type embryos were
found. Moreover Pold1
exo/2 mice, which were generated by
Table 1. Genotypes of progeny from Pold1
+/2 intercrosses.
Age No. (%) of offspring with genotype
No. (%)
resorbed total
+/++ /22 /2
Neonate 88 (34) 168 (66) 0 (0) 256
E9.5 8 (24) 13 (38) 0 (0) 13 (38) 34
E7.5 10 (29) 16 (47) 0 (0) 8 (24) 34
E4.5 6 (29) 8 (38) 7 (33) NA
a 21
E3.5 10 (25) 18 (45) 12 (30) NA 40
aNA, not available.
doi:10.1371/journal.pone.0004184.t001
allele (the two overlap) and the 6.4-kb fragment corresponds to the Pold1
2 allele. In NheI digestion, the 14.6-kb fragment represents the wild-type
allele while the 6.0-kb fragment represents both Pold1
2 and Pold1
exo alleles. (F) DNA sequencing of RT-PCR products from heterozygous Pold1
+/2 and
Pold1
exo/+ ES cells. Aspartic acid, D, was substituted with alanine, A, in Pold1
exo alleles. (G) Schematic represents the results of nucleotide sequencing
the 39RACE products derived from Pold1
2 alleles in Pold1
+/2 ES cells. Primers P4 and P5 were used for 39RACE repeated amplification. 39RACE
products from Pold1
2 alleles were distinguished by means of sequencing the D400A substitution. (H) Immunoblot analysis of two pairs of extracts
derived from E12.5 whole embryos performed with anti-Pold1 and anti-b-actin (control) antibodies; one pair compares Pold1
+/2 and Pold1
+/+ from the
same litter of embryos while the other compares Pold1
exo/exo and Pold1
+/+ embryos.
doi:10.1371/journal.pone.0004184.g001
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exo/exo and Pold1
+/2 mice, could give birth
and were also apparently normal and fertile (Table 2). These
results showed that for mouse development, Pold 39–59 exonucle-
ase activity is dispensable and one Pold1
exo allele is sufficient.
Although Pold1
exo/exo and Pold1
exo/2 mice were developmen-
tally normal, they frequently died with abnormally swollen
thymuses between 3 and 8 months (9 out of 28 Pold1
exo/exo
animals and 5 out of 14 Pold1
exo/2 animals) (Fig. 5A), and many of
the surviving mice without swollen thymuses developed nodules on
their tails after 12 months (Fig. 5B). These observations are
consistent with typical cancer symptoms owing to the lack of Pold
39–59 exonuclease activity [16,17]. Histological analysis of swollen
thymuses showed a homogenous population of cells with a high
nuclear to cytoplasmic ratio and frequent mitoses, typical
morphological features of lymphoblastic lymphoma (date not
shown). Pold1
exo/+ mice and wild-type mice did not express such
phenotypes on their thymus and tails (more than 20 animals
observed for each genotype). Thus, the lack of Pold 39–59
exonuclease activity also increased cancer susceptibility in
C57BL/6 mice like as those mixed with C57BL/6J and 129/SvJ
as previously seen [17]. Furthermore, we found that Pold1
exo/2
mice developed similar tumors.
Discussion
So far the function of Pold had been mainly studied by
biochemical approaches and yeast genetics. This present study
revealed the function of Pold by examining its Pold1 knock out
mice. Although many DNA polymerases have been clarified, the
physiological role of three DNA polymerases directly involved in
Figure 2. Morphological analysis of blastocysts and outgrowths from blastocysts. (A) The appearance of mutant embryos. E3.5 and E4.5
embryos were flushed out from the uteri. E4.5 embryos were cultured for 2 hr in M2 medium. After taking photographs under bright-field conditions,
E3.5 and E4.5 embryos were genotyped by PCR. (B) Impaired proliferation of Pold1-deficient blastocyst outgrowths in vitro. Blastocysts were
harvested at E3.5, cultured in vitro for several days, and subsequently genotyped by PCR. Black horizontal bar indicates 50 mm.
doi:10.1371/journal.pone.0004184.g002
Pold in Mouse Embryogenesis
PLoS ONE | www.plosone.org 5 January 2009 | Volume 4 | Issue 1 | e4184Figure 3. Pold1 deficient embryos showed defective DNA synthesis. DNA synthesis was observed by determining BrdU incorporation in
cultured blastocysts in vitro. (A) E3.5 embryos were cultured for 24 hr, then cultured in the presence of BrdU for 3 hr. After indirect
immunofluorescence using anti-BrdU (green) and anti-pHH3 (red) antibodies and counterstained with DAPI (blue), embryos were genotyped by PCR.
(B) E3.5 embryos were cultured for 3 days, cultured in the presence of BrdU for 3 hr, and processed for immunostaining against BrdU (green) and
pHH3 (red) and DAPI counterstaining (blue). The genotype of each embryo was subsequently determined by PCR. White horizontal bar indicates
50 mm.
doi:10.1371/journal.pone.0004184.g003
Figure 4. Spontaneous apoptosis detected in Pold1 deficient embryos. Spontaneous apoptosis was analyzed by TUNEL assay. TUNEL-
positive cells appeared in Pold1-deficient blastocyst outgrowths. After taking a photo, the genotype of each embryo was determined by PCR. White
horizontal bar indicates 50 mm.
doi:10.1371/journal.pone.0004184.g004
Pold in Mouse Embryogenesis
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assessed in Pol knockout mice. In this study, we found that Pold
disrupted mice suffered from embryonic lethality after E4.5. To
date, three DNA polymerases, Polb [25,26], Polc [27] and Polf
[28] are known to lead to embryonic death in mice (after E18.5,
E7.5 and E9.5, respectively) upon disruption. Pold absence caused
lethality at an earlier embryonic stage than these aforementioned
DNA polymerases. This is consistent with the notion that Pold has
a fundamental role in cellular proliferation.
Genetic studies in yeast [4] and in vitro biochemical studies [8,9]
have shown that Pold is indispensable for nuclear DNA replicative
synthesis. However, in this presented study, we found no obvious
abnormality in functionally Pold1-null mouse embryos before
implantation. Since we could count more than 60 nuclei in a one
day cultured Pold1
2/2 blastocyst (data not shown), at least 6 times
of cell division were performed between fertilization and the
embryonic death. To investigate whether these embryos could
proceed with pre-implantation development without Pold1
protein, we performed immunostaining of Pold1
2/2 blastocysts
with anti-Pold1 antibodies. Pold1 protein was not only found in
Pold1
+/2 and Pold1
+/+ embryos but also in Pold1
2/2 embryos,
which had no apparent cell cycle defect (Fig. S1). In addition,
published microarray data indicated that the Pold1 mRNA
presents in mouse unfertilized eggs and early embryos where
zygotic gene expression have not started [29]. These results
suggested that maternal Pold1 stockpiles could support for
proceeding pre-implantation development of Pold1-null embryos.
Similar peri-implantation lethalities have been found when
disrupting other components required for nuclear DNA replica-
tion such as FEN1 [30], CDC45 [31], and Psf1 [32]. Maternal
compensation is also thought to explain why in zebrafish, Pold1-
null embryos developed to a late embryonic state [15].
Pold1
2/2 embryos showed a cell proliferation defect and a DNA
synthetic defect in in vitro blastocyst outgrowths. These observations
show that no redundant activity for Pold exists in mammalian
development and affirm the known Pold cellular function require-
ment in chromosomal DNA synthesis. Our Pold results also show
frequent spontaneous apoptotic cells and few mitotic cells in 3 day
cultured Pold1
2/2 blastocyst outgrowths (Fig. 3B), indicating the
existence of a DNA replication checkpoint in eukaryotic cells to
guarantee an accurate transmission of chromosomal DNA to
subsequent generations [33]. Disrupting DNA replication is known
to activate this checking system, resulting in either arresting the cell
cycle before mitosis initiation in order to have the disruption
removed or tolerated, or causing apoptosis on cells that harbor the
disruption [34]. Our observations in 3 day cultured Pold1
2/2
blastocystoutgrowthsisanexpectedcellularresponsetothedefective
DNA replication caused by Pold disruption.
Although heterozygous Pold1
+/2 mice showed a reduction in the
amount of Pold1 protein (Fig. 1H), there were no apparent
developmental abnormalities. In addition, Pold1
2/2 embryos
developed normally until the blastocyst stage despite zygotic gene
expression starting at the two cell stage. These observations
showed that in vivo, the Pold1 gene expresses more than the
necessary amount of gene products needed for development and
indicate that the gross quantity of Pold1 protein does not regulate
the mammalian developmental process.
In contrast to the functional disruption seen with the Pold1 gene, it
has been seen that homozygous deficient (Pold1
exo/exo) mice for Pold
39–59 exonuclease activity develop normally, although they are more
susceptible to tumors [16,17]. We found similar phenotypes in
Pold1
exo/2 mice. Similar types of tumors were observed in both
Pold1
exo/exo and Pold1
exo/2 mice lacking exonuclease activity. The
tumorigenesis in Pold1
exo/2 mice revealed more clearly that one
Pold1
exo allele was sufficient for increasing cancer susceptibility
without Pold1
+ allele and Pold 39–59 exonuclease activity expressed a
dominant effect on the suppression of tumorigenesis.
Most of our knowledge about DNA replication has accumulated
from biochemical studies and genetic studies on lower eukaryotes.
But these models do not necessarily correlate well with higher
eukaryotic systems because eukaryotic systems have many more
types of differentiated cells with more complicated interactions. For
example, a study of DNA polymerase genes during the development
of mouse testis suggested that Pole did not participate in meiotic
replication, though it is thought that this polymerase cooperates with
two others, Pola and Pold, in DNA replication based on other
models [35]. Additionally, reliability of DNA replication, in which
Pold is involved, affects cancer susceptibility in higher eukaryotes.
Our present findings revealed the physiological functions of Pold
during mammalian development by using Pold1 gene targeted mice,
indicating that the molecular function of Pold is conserved at least in
mammalian early embryogenesis and that its 39–59 exonuclease
activity is necessary for tumor suppression. Further analysis on the
physiological function of replicativeDNA polymerases willshed light
on the mechanism of DNA replication in mammalian systems,
adding critical insight to genomic instability.
Materials and Methods
Animals
Animals were maintained in a specific pathogen-free space
under a 12-h light/dark regime with access to food and water ad
libitum. Experimental procedures were in accordance with the
Guide for the Care and Use of Laboratory Animals of the Science
Council of Japan and were approved by the Animal Experiment
Committee of Osaka University.
Construction of the gene targeting vector
The targeting vector was cloned into pBlueScriptII (Invitrogen)
and consisted of four fragments. The bacterial artificial chromo-
some (BAC) clone RP23-406H21 comprised the murine genomic
Pold1 coding region. For homologous recombination, a 39
fragment (6.9-kb) from the intron between exons 10 and 11 to
exon 25 was extracted with EcoRI and SacI digestion from the
Table 2. Offspring of 39–59 exonuclease deficient mice.
Parents (male6female) +/+ exo/+ exo/exo total
Pold1
exo/+6Pold1
exo/+ 23 39 14 76
Pold1
+/26Pold1
exo/exo -9 8 1 7
doi:10.1371/journal.pone.0004184.t002
Figure 5. Lack of Pold 39–59 exonuclease activity causes tumors.
(A) Swollen thymus in 4-month old Pold1
exo/2 mice. Th: thymus, H:
heart. (B) Tail with nodule in 14-month old Pold1
exo/2 mice.
doi:10.1371/journal.pone.0004184.g005
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between exons 10 and 11 contained a mutation which changes the
D400 codon to an alanine codon. This mutated fragment was
generated by repeated PCR using the oligonucleotide 59-
CAGAACTTTGCCCTCCCATACCTC-39 and its complemen-
tary oligonucleotide (alanine codon is underlined). Floxed
fragments, which contained the 800-bp simian virus 40 (SV40)
splice/polyadenylylation signal [36] and a neomycin resistance
cassette for positive selection, were inserted between the 59 and 39
fragments for homologous recombination and in the same
orientation relative to the Pold1 gene. A DT-A fragment for
negative selection was placed outside the 59 fragment for
homologous recombination [37]. The targeting vector was verified
by restriction digestion and nucleotide sequencing.
Generation of Pold1 gene targeting mice
The SacI-linearized targeting vector was electroporated into
C57BL/6J embryonic stem (ES) cells (InGenious targeting, New
York). Candidate recombinant clones were selected by growth in the
presenceofG418.Adequate homologousrecombinantswereverified
by PCR, Southern blotting and DNA sequencing. For PCR, primers
P0 (59-TTGACCTCCGCACTCATCAG-39) and P2 (59-CACCA-
GACCAACTGGTAATGG-39) were used with LA Taq polymerase
(TaKaRa). For Southern blotting, genomic DNA was completely
digested by DraIo rNheI, and probed with external [
32P]dCTP-
labeled DNA fragments as indicated in Fig. 1B. Injection of the
recombinant ES cells into Balb/c blastocysts generated chimeric
mice. The chimeras were mated with C57BL/6J female mice to
generate heterozygous Pold1
+/2 mice. The Pold1
exo/+ mice were
generated by crossing Pold1
+/2 mice and Sycp1-Cre transgenicmice.
All mutations used in this study maintained on the inbred (C57BL/6)
background. For genotyping these Pold1 targeting mice, PCRs were
performed with three primers: P1 (59-GGAGTCCAGGTGTG-
CGTTAC-39), P2 (59-CACCAGACCAACTGGTAATGG-39)a n d
P3 (59-CAGATTCCCCTCTGTGCATC-39). PCR was done at
94uC for 1 min, followed by 30 cycles at 94uCf o r1m i n ,6 0 uCf o r
30 s, and 72uCf o r4 0sw i t hEX Taq polymerase (TaKaRa).
Establishment of Pold1
exo/+ ES cell lines
To obtain Pold1
exo/+ ES cells, circular pCre-Pac plasmids were
electroporated into Pold1
+/2 ES cells [20]. The candidate ES cells
were selected transiently with puromycin (1 mg/ml; Sigma). Each
genotype of these Cre-mediated recombinants was confirmed by
PCR and Southern blotting.
Generation of Sycp1-Cre Tg mice
The plasmid to create Sycp1-Cre Tg mice was constructed from
two fragments. One fragment was the promoter sequence from the
murine Sycp1 gene, which expressed in male germ cells, including
the region from 2737 to +87 relative to the transcription start site
[38]. The other was the Cre coding sequence containing the
nuclear localized signal and polyadenylation signal. Both frag-
ments were inserted into the pBluescript II (Stratagene) between
the SpeI and HindIII sites. Then the plasmid was digested by SalI
and NotI and the purified fragment was microinjected into
fertilized eggs derived from C57BL/6 mice. We screened the
offspring for an insertion of the transgene by genomic PCR using
the Cre specific primers (59-CTGAGAGTGATGAGGTTC-39)
and (59-CTAATCGCCATCTTCCAGCAG-39).
RT-PCR and 39RACE analysis
Total RNA was isolated from ES cells using TRIzol Reagent
(GIBCO) and digested with DNaseI to remove contaminating
genomic DNA. cDNA was prepared by using Superscript III
Reverse Transcriptase (Invitrogen) with an oligo(dT)25 primer.
PCR was performed with the Pold1 59-terminal primer (59-
GGCGTATCTTGTGGCGGGAA-39) and 39-terminal primer
(59-CCTTGTCCCGTGTCAGGTCA-39). For 39RACE, reverse
transcription was performed with an adaptor sequence conjugated
to an oligo(dT)17 primer while the subsequently repeated PCRs
used primers P4 (59-TCATGGCCCTTCTCCATTTC-39), P5
(59-TGGAGCTGCCAGCTGGAAAG-39) (Fig. 1G) and two
kinds of adaptor primers.
Western blotting
E12.5 whole embryos were lysed in ice-cold lysis buffer (0.1% NP-
40, 50 mM Tris-HCl [pH 7.2], 250 mM NaCl, 2 mM EDTA, 10%
glycerol, 1 mM PMSF, 3 mg/ml leupeptine, 3 mg/ml pepstatineA,
10 mg/mlaprotinin),homogenizedwithPolytronandthensonicated
briefly. The lysates were cleared by centrifugation at 20,0006gf o r
20 min. The supernatants were collected and used for Western
blotting. For Western blotting, anti-Pold1 C-terminal region
polyclonal antibody (C-20, Santa Cruz) and anti-b-actinmonoclonal
antibody (AC-15, Sigma) were used.
Blastocyst culture and genotyping
All embryos were generated by natural mating. The morning of
the day on which the vaginal plug was detected was designated as
day E0.5. Embryos were collected on E3.5 or E4.5 by flushing the
uteri with M2 medium (Sigma). For culture, embryos were then
cultured in complete ES cell medium containing leukemia
inhibitory factor. In BrdU treated embryos, embryos were
additionally cultured in the ES cell medium supplemented with
10 mM BrdU for 3 hours.
For genotyping, individual embryos were lysed by incubation at
55uC overnight in 5 ml PCR lysis buffer (10 mM Tris-HCl
[pH 8.0], 50 mM KCl, 2 mM MgCl2, 0.45% NP-40, 0.45%
Tween 20, 0.2 mg/ml of proteinase K) [39]. To detect each
mutated allele, PCRs were performed with the same three primers
as mice genotyping: P1, P2 and P3. PCR was done at 94uC for
1 min, followed by 35 cycles at 94uC for 1 min, 58uC for 30 s, and
72uC for 50 s with LA Taq polymerase (TaKaRa).
Immunocytochemistry and apoptotic cell detection
Embryos were washed in phosphate-buffered saline (PBS)
containing 1.5% bovine serum albumin (BSA), fixed in 4%
paraformaldehyde in PBS for 30 min at 4uC, and then permeabi-
lized for 20 min at room temperature in PBS with 0.3% Triton X-
100 and 1.5% BSA. For BrdU-treated embryos, DNA was
denatured after permeabilization with 0.25 N HCl and 0.5% Triton
X-100 for 20 min at room temperature and washed extensively in
PBS with 1.5% BSA. Embryos were incubated with specific primary
antibodies overnight at 4uC. The primary antibodies used in this
study were mouse anti-BrdU (Dako Cytomation) and rabbit anti-
phosphohistone H3 (Ser-10) (Cell Signaling). The fluorescence-
labeled secondary antibodies were purchased from Molecular
Probes. TUNEL (terminal deoxynucleotidyltransferase-mediated
dUTP-biotin nick end labeling) assays to detect apoptotic cells were
performed by using the In Situ Cell Death Detection Kit (Roche).
Supporting Information
Figure S1 Pold1 protein exists in Pold1
2/2 blastocysts. To check
if Pold1 gene products are present in Pold1 deficient embryos, we
immunostained blastocysts harvested from Pold1
+/2 intercross
using two kinds of anti-Pold1 polyclonal antibodies, H300 and
C20 (purchased from Santa Cruz) and counterstained with DAPI.
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by PCR. White horizontal bar indicates 50 mm.
Found at: doi:10.1371/journal.pone.0004184.s001 (0.73 MB TIF)
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